Willow Bioscience (TSE: WLLW: OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive Vancouver with news the company has hit a major milestone in their development. Peters talks about this significant step. Peters also talked about the company as a whole and what separates them from others in their sector.
Willow Bioscience takes first major step towards development of pharmaceutical grade CBG
Quick facts: Willow Biosciences Inc.
Price: 0.7 CAD
Market Cap: $55.22 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE